Navigation Links
Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
Date:8/1/2008

IRVING, Texas, Aug. 1 /PRNewswire/ -- CDX Holdings, a newly-formed holding company that is the parent company of Caris Diagnostics (Caris Dx) and Caris Molecular Diagnostics (CMDx), announced today that George Poste, D.V.M., Ph.D, F.R.C. Path, F.R.S., will be expanding his involvement with the company, serving as Non-Executive Vice Chairman and Chief Scientific Advisor of CDX Holdings and Non-Executive Chairman of CMDx. Dr. Poste has been a Director of Caris Dx, and now CDX Holdings, since November of 2006. He also acts as Senior Technical Advisor to Caris, Ltd., which owns a controlling stake in CDX Holdings.

Dr. Poste is Chief Scientist of the Complex Adaptive Systems Initiative and Director of The Biodesign Institute at Arizona State University. The research programs led by Dr. Poste combine research in biotechnology, nanotechnology, materials science and advanced computing. He also serves as Chief Executive of Health Technology Networks, a consulting firm that specializes in the application of genomic technologies and computing in healthcare. From 1992 to 1999, he was Chief Science and Technology Officer and president of Research & Development for SmithKline Beecham, where he oversaw the registration of 31 drug, vaccine and diagnostic products. Dr. Poste is a Fellow of the Royal College of Pathologists, a Fellow of the Royal Society and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution of Stanford University and a member of the Council for Foreign Relations.

"George has been an invaluable asset to Caris since he first joined our Board in 2006. We look forward to getting the benefit of the additional contributions that George now will be able to offer in his more active role within our companies," said David D. Halbert, Chairman of CDX Holdings. "His understanding and foresight in diagnostics and personalized medicine is tremendous. He was instrumental in formulating our strategy that brought us into molecular diagn
'/>"/>

SOURCE CDX Holdings
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
2. George Butler Joins Bionovos Board of Directors
3. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
4. Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity
5. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
6. Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
7. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
8. Fred Hutchinson Cancer Research Center and NSB POSTECH, Inc. to Collaborate on Development of New Class of Proteomic Microarrays
9. Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA
10. Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site
11. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Ald...eNASDAQOMXconferenceonTuesday,December1stat1:45PMG...vialiveaudiobroadcastovertheInternetavailableat h...rscanclickthe"Webcast"icontoaccessthisfile. ,, ...ScienceandHighTechnologycompany.Itschemicalandbioc...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Ne...anyfocusedondevelopingandcommercializingnovelpainm...o,PresidentandChiefExecutiveOfficer,isscheduledtop...nce,tobeheldDecember1-2,2009atTheNewYorkPalaceHote...lieri,ChiefFinancialOfficer,willbeavailabletorespo...
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswith..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZ...globalbiopharmaceuticalcompanyfocusedonendocrineth...afromaPhase2studywithitstargetedcytotoxicpeptideco...ancedorrecurrentendometrialcancer.Inapersonalizedh...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/-...atRandyScott,GenomicHealth,sExecutiveChairman,will...enceinNewYorkCityonTuesday,December1,2009at10:00a....webcastofthepresentation,visittheInvestorRelations...genomichealth.com .Pleaseconnecttothewebsiteatleas...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...apeutics,Inc. (MTI), a company that discovers and ...gs, announces that it has retained Marquant Partne...se on its strategic and partnering,opportunities, ...lders., This appointment follows a significant am...financial and pharmaceutical companies after its,a...
...a-,Aldrich Corporation announced today that it wil...dnesday, March 19, 2008 at its Life Science & High...uis, Mo. 63103, The event will begin at 8:30 a.m....be webcast over the Sigma-Aldrich website at, http...Sigma-Aldrich is a leading Life Science and High,T...
...Deliver Electronic X-ray-Based, Therapy Directly ...tings, SUNNYVALE, Calif., March 17 Xoft, Inc., t...ance from the U.S. Food & Drug,Administration (FDA...m, a,proprietary technology platform designed to d...iation treatment in minimally-shielded,clinical se...
Other Biology Technology:Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3FDA Clears Expanded Use of Xoft's Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications 2
(Date:11/23/2009)...alifornia biomedical engineer and cardiologist Tzu...p clinicians distinguish cardiac emergencies requi...eable with drugs and lifestyle change. , Angiogr...teries feeding the heart, offer an inside view of ...els, often revealing deposits of a dangerous fatty...
(Date:11/23/2009)...General Medical Sciences (NIGMS), part of the Nati...3 million for grants in scientific areas it identi...the GO grant program to stimulate biomedical resea...erican Recovery and Reinvestment Act (Recovery Act...o have a significant impact on a field of biomedic...
(Date:11/23/2009)... is Director of the Interuniversity Professorship ...and the University of the Basque Country. The Prof...as other experts such as researchers in the fields...ts in ethics. , The Interuniversity Professorshi... of Deusto and the Basque Country was created in 1...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2A tiny frozen microbe may hold clues to extraterrestrial life 8822 1A tiny frozen microbe may hold clues to extraterrestrial life 8822 2Advance in understanding cellulose synthesis 8820 1Advance in understanding cellulose synthesis 8820 2Advance in understanding cellulose synthesis 8820 3Keep Safety in Mind While Cooling Off in the Water 48824 1Keep Safety in Mind While Cooling Off in the Water 48824 2
... Four hundred researchers tapping the massive flow...30 to share their recent developments at the 2nd A...tute (DOE JGI) User Meeting. DOE JGI is the world,...ughput DNA sequencing available to a diverse resea...erwise would not have access to such a resource to...
... A team of Canadian researchers, lead by Dr. Susan...iction and Mental health (CAMH), discovered a dist...mposed of two different types of dopamine receptor...n understanding and treating schizophrenia. , Publ...f Sciences USA (Rashid et al., 2007), this importa...
... Some day, heart attack survivors might have a pat...t, to replace areas that died during their attack....et new ones that can grow in place, rather than be...ged or weak blood vessels might get a new “natural...se possibilities are all within reach, and could t...
Other Biology News:New dopamine brain target discovered 2Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Glycogen Coprecipitant from Bioline
Biology Products: